Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 74.75
+0.20 (0.27%)
Jul 10, 2026, 5:29 PM CET
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 7.76 billion as of July 10, 2026. Its market cap has decreased by -15.30% in one year.
Market Cap
7.76B
Enterprise Value
7.96B
Revenue
7.39B
Ranking
n/a
PE Ratio
32.84
Stock Price
74.75
Market Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 7.76B, a decrease of -10.10%. That is a compound annual growth rate of -6.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.76B | -19.16% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 165.94B |
| Getinge AB | 56.11B |
| Sectra AB | 55.91B |
| Medicover AB | 36.09B |
| BioGaia AB | 11.99B |
| Xvivo Perfusion AB | 8.87B |
| RaySearch Laboratories AB | 8.00B |
| Synsam AB | 7.86B |